GLP-3

GLP-3 is an innovative synthetic peptide consisting of around 39 amino acids. This compound is currently under investigation and researchers are particularly interested in its distinct mechanism of action, which involves targeting multiple receptor pathways simultaneously. By acting as a triple agonist, GLP-3 interacts with glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors.